Switching to emicizumab: A prospective surveillance study in haemophilia A subjects with inhibitorsÉvemie Dubé, Georges‐Étienne Rivard, N. Zourikian et al.|Haemophilia|2022Cited by 3
The diagnosis of a haemophilia A carrier over 2 decadesÉvemie Dubé, Georges‐Étienne Rivard, Julie Gauthier et al.|Haemophilia|2020Cited by 2
Evaluation of anti‐factor VIII antibodies in haemophilia A subjects switching products following a provincial tenderÉvemie Dubé, Georges‐Étienne Rivard, Clémence Merlen et al.|Haemophilia|2021Cited by 1
A prospective surveillance study in haemophilia B patients following a population switch to recombinant factor IX (nonacog gamma)Évemie Dubé, Georges‐Étienne Rivard, Margaret R. Warner et al.|Haemophilia|2021Cited by 0